{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:59:53Z","timestamp":1785527993252,"version":"3.56.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["MOP-11-51-31; RFN 152985"],"award-info":[{"award-number":["MOP-11-51-31; RFN 152985"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["159815"],"award-info":[{"award-number":["159815"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["162303"],"award-info":[{"award-number":["162303"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015569","name":"Consortium canadien en neurod\u00e9g\u00e9n\u00e9rescence associ\u00e9e au vieillissement","doi-asserted-by":"publisher","award":["MOP-11-51-31-team 1"],"award-info":[{"award-number":["MOP-11-51-31-team 1"]}],"id":[{"id":"10.13039\/100015569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009408","name":"Fondation Brain Canada","doi-asserted-by":"publisher","award":["CFI Project 34874"],"award-info":[{"award-number":["CFI Project 34874"]}],"id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009408","name":"Fondation Brain Canada","doi-asserted-by":"publisher","award":["33397"],"award-info":[{"award-number":["33397"]}],"id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["FRQS"],"award-info":[{"award-number":["FRQS"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["2020-VICO-279314"],"award-info":[{"award-number":["2020-VICO-279314"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["2024 VICO-356138"],"award-info":[{"award-number":["2024 VICO-356138"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["https:\/\/doi.org\/10.69777\/324345"],"award-info":[{"award-number":["https:\/\/doi.org\/10.69777\/324345"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["https:\/\/doi.org\/10.69777\/356138"],"award-info":[{"award-number":["https:\/\/doi.org\/10.69777\/356138"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["https:\/\/doi.org\/10.69777\/312994"],"award-info":[{"award-number":["https:\/\/doi.org\/10.69777\/312994"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012498","name":"Alzheimer Society Research Program","doi-asserted-by":"publisher","award":["0000000158"],"award-info":[{"award-number":["0000000158"]}],"id":[{"id":"10.13039\/100012498","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00259-026-07886-3","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T23:47:07Z","timestamp":1779407227000},"page":"5644-5658","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Visual versus quantitative tau-PET Braak staging in Alzheimer\u2019s disease using [18F]MK6240"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3957-0284","authenticated-orcid":false,"given":"Arthur C.","family":"Macedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Provost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Soucy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlette","family":"Haeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Therriault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Trudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine","family":"Rahmouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Fernandez-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9tienne","family":"Aumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Lebrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tevy","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Ali","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gleb","family":"Bezgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Tissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"Servaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hopewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris Hung-Hsin","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gallen","family":"Triana-Baltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmuth C.","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a L.","family":"Benedet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gassan","family":"Massarweh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Klostranec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharick A.","family":"Pascoal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"7886_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207\u201316.","journal-title":"Lancet Neurol"},{"issue":"8","key":"7886_CR2","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 2024;20(8):5143\u201369.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"7886_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae043","volume":"6","author":"AC Macedo","year":"2024","unstructured":"Macedo AC, Therriault J, Tissot C, et al. Predicting functional decline in aging and Alzheimer\u2019s disease with PET-based braak staging. Brain Commun. 2024;6(2):fcae043.","journal-title":"Brain Commun"},{"issue":"9","key":"7886_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70624","volume":"21","author":"L Trudel","year":"2025","unstructured":"Trudel L, Therriault J, Macedo AC, et al. Rates of clinical progression according to biological Alzheimer\u2019s disease stages. Alzheimers Dement. 2025;21(9):e70624.","journal-title":"Alzheimers Dement"},{"issue":"Pt 5","key":"7886_CR5","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Sch\u00f6ll M, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain. 2016;139(Pt 5):1551\u201367.","journal-title":"Brain"},{"issue":"524","key":"7886_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau5732","volume":"12","author":"R La Joie","year":"2020","unstructured":"La Joie R, Visani AV, Baker SL, et al. Prospective longitudinal atrophy in Alzheimer\u2019s disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. 2020;12(524):eaau5732.","journal-title":"Sci Transl Med"},{"issue":"5","key":"7886_CR7","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll M, Lockhart SN, Schonhaut DR, et al. PET imaging of tau deposition in the aging human brain. Neuron. 2016;89(5):971\u201382.","journal-title":"Neuron"},{"issue":"8","key":"7886_CR8","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2967\/jnumed.122.265200","volume":"64","author":"AC Macedo","year":"2023","unstructured":"Macedo AC, Tissot C, Therriault J, et al. The use of tau PET to stage Alzheimer disease according to the Braak staging framework. J Nucl Med. 2023;64(8):1171\u20138.","journal-title":"J Nucl Med"},{"issue":"2","key":"7886_CR9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.14283\/jpad.2024.15","volume":"11","author":"AC Macedo","year":"2024","unstructured":"Macedo AC, Dur\u00e7o DFPA, Tissot C, et al. Clinical correlates of the PET-based Braak staging framework in Alzheimer\u2019s disease. J Prev Alzheimers Dis. 2024;11(2):414\u201321.","journal-title":"J Prev Alzheimers Dis"},{"key":"7886_CR10","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/brain\/aww023","volume":"139","author":"AJ Schwarz","year":"2016","unstructured":"Schwarz AJ, Yu P, Miller BB, et al. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages. Brain. 2016;139:1539\u201350.","journal-title":"Brain"},{"issue":"7","key":"7886_CR11","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1001\/jamaneurol.2020.0528","volume":"77","author":"AD Fleisher","year":"2020","unstructured":"Fleisher AD, Pontecorvo MJ, Devous MD Sr. Positron emission tomography imaging with [18F]flortaucipir and postmortem assessment of Alzheimer disease neuropathologic changes. JAMA Neurol. 2020;77(7):829\u201339.","journal-title":"JAMA Neurol"},{"issue":"6","key":"7886_CR12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s43587-022-00204-0","volume":"2","author":"J Therriault","year":"2022","unstructured":"Therriault J, Pascoal TA, Lussier FZ, et al. Biomarker modeling of Alzheimer\u2019s disease using PET-based Braak staging. Nat Aging. 2022;2(6):526\u201335.","journal-title":"Nat Aging"},{"issue":"9","key":"7886_CR13","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1093\/brain\/awaa180","volume":"143","author":"TA Pascoal","year":"2020","unstructured":"Pascoal TA, Therriault J, Benedet AL, et al. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles. Brain. 2020;143(9):2818\u201330.","journal-title":"Brain"},{"key":"7886_CR14","unstructured":"Lantheus Holdings, Inc. Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer\u2019s Disease. Lantheus Holdings, Inc. https:\/\/lantheusholdings.gcs-web.com\/news-releases\/news-release-details\/lantheus-announces-fda-acceptance-new-drug-application-mk-6240. Accessed January 20, 2026"},{"issue":"4","key":"7886_CR15","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2019.4421","volume":"77","author":"J Therriault","year":"2020","unstructured":"Therriault J, Benedet AL, Pascoal TA, et al. Association of apolipoprotein E \u03b54 with medial temporal tau independent of amyloid-\u03b2. JAMA Neurol. 2020;77(4):470\u20139.","journal-title":"JAMA Neurol"},{"issue":"3","key":"7886_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):270\u20139.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"7886_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"7886_CR18","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.neuroimage.2012.02.084","volume":"61","author":"M Reuter","year":"2012","unstructured":"Reuter M, Schmansky NJ, Rosas HD, Fischl B. Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage. 2012;61(4):1402\u201318.","journal-title":"Neuroimage"},{"issue":"3","key":"7886_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","volume":"13","author":"CR Jack Jr","year":"2017","unstructured":"Jack CR Jr, Wiste HJ, Weigand SD, et al. Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease. Alzheimers Dement. 2017;13(3):205\u201316.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"7886_CR20","doi-asserted-by":"publisher","first-page":"8074","DOI":"10.1002\/alz.14315","volume":"20","author":"SE Schindler","year":"2024","unstructured":"Schindler SE, Petersen KK, Saef B, et al. Head-to-head comparison of leading blood tests for Alzheimer\u2019s disease pathology. Alzheimers Dement. 2024;20(11):8074\u201396.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"7886_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2967\/jnumed.120.245209","volume":"62","author":"J Therriault","year":"2021","unstructured":"Therriault J, Benedet AL, Pascoal TA, et al. Determining amyloid-\u03b2 positivity using 18F-AZD4694 PET imaging. J Nucl Med. 2021;62(2):247\u201352.","journal-title":"J Nucl Med"},{"issue":"2","key":"7886_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/jamaneurol.2022.4485","volume":"80","author":"J Therriault","year":"2023","unstructured":"Therriault J, Vermeiren M, Servaes S, et al. Association of phosphorylated tau biomarkers with amyloid PET vs tau PET. JAMA Neurol. 2023;80(2):188\u201399.","journal-title":"JAMA Neurol"},{"key":"7886_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neurobiolaging.2024.09.009","volume":"144","author":"AC Macedo","year":"2024","unstructured":"Macedo AC, Therriault J, Tissot C, et al. Modeling the progression of neuropsychiatric symptoms in Alzheimer\u2019s disease with PET-based Braak staging. Neurobiol Aging. 2024;144:127\u201337.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"7886_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.2967\/jnumed.122.264434","volume":"64","author":"C Tissot","year":"2023","unstructured":"Tissot C, Servaes S, Lussier FZ, et al. The association of age-related and off-target retention with longitudinal quantification of [18F]MK6240 tau PET. J Nucl Med. 2023;64(3):452\u20139.","journal-title":"J Nucl Med"},{"key":"7886_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2012.00171","volume":"6","author":"A Klein","year":"2012","unstructured":"Klein A, Tourville J. 101 labeled brain images and a consistent human cortical labeling protocol. Front Neurosci. 2012;6:171.","journal-title":"Front Neurosci"},{"issue":"1","key":"7886_CR26","volume":"12","author":"I Sonni","year":"2020","unstructured":"Sonni I, Lesman-Segev OH, Baker SL, et al. Evaluation of a visual interpretation method for tau-PET with 18F-flortaucipir. Alzheimers Dement (Amst). 2020;12(1):e12133.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"7","key":"7886_CR27","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s00259-020-05152-8","volume":"48","author":"K Provost","year":"2021","unstructured":"Provost K, Iaccarino L, Soleimani-Meigooni DN, et al. Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts. Eur J Nucl Med Mol Imaging. 2021;48(7):2259\u201371.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7886_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13195-018-0402-y","volume":"10","author":"TA Pascoal","year":"2018","unstructured":"Pascoal TA, Shin M, Kang MS, et al. In vivo quantification of neurofibrillary tangles with [18F]MK-6240. Alzheimers Res Ther. 2018;10:74.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"7886_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239\u201359.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"7886_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","volume":"13","author":"CR Jack Jr","year":"2017","unstructured":"Jack CR Jr, Wiste HJ, Weigand SD, et al. Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease. Alzheimers Dement. 2017;13(3):205\u201316.","journal-title":"Alzheimers Dement"},{"key":"7886_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, et al. National Institute on Aging\u2013Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement. 2012;8:1\u201313.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"7886_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121945","volume":"10","author":"B Diedenhofen","year":"2015","unstructured":"Diedenhofen B, Musch J. Cocor: a comprehensive solution for the statistical comparison of correlations. PLoS One. 2015;10(3):e0121945.","journal-title":"PLoS One"},{"key":"7886_CR33","doi-asserted-by":"publisher","unstructured":"Rosa-Neto P, Macedo AC, Therriault J, et al. Tau spreading precedes the increase in tau load in Alzheimer\u2019s disease. Res Sq. 2025. https:\/\/doi.org\/10.21203\/rs.3.rs-5619837\/v1. Preprint.","DOI":"10.21203\/rs.3.rs-5619837\/v1"},{"key":"7886_CR34","volume-title":"Handbook of Inter-Rater Reliability: The Definitive Guide to Measuring the Extent of Agreement among Raters","author":"KL Gwet","year":"2014","unstructured":"Gwet KL. Handbook of Inter-Rater Reliability: The Definitive Guide to Measuring the Extent of Agreement among Raters. 4th ed. Gaithersburg, MD: Advanced Analytics, LLC; 2014.","edition":"4th ed"},{"issue":"1","key":"7886_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52265-x","volume":"15","author":"P Kunach","year":"2024","unstructured":"Kunach P, Vaquer-Alicea J, Smith MS, et al. Cryo-EM structure of Alzheimer\u2019s disease tau filaments with PET ligand MK-6240. Nat Commun. 2024;15(1):8497.","journal-title":"Nat Commun"},{"issue":"10","key":"7886_CR36","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.2967\/jnumed.115.171678","volume":"57","author":"ED Hostetler","year":"2016","unstructured":"Hostetler ED, Walji AM, Zeng Z, et al. Preclinical characterization of 18F-MK-6240, a promising PET tracer for in vivo quantification of human neurofibrillary tangles. J Nucl Med. 2016;57(10):1599\u2013606.","journal-title":"J Nucl Med"},{"issue":"4","key":"7886_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.70033","volume":"16","author":"MR Vermeiren","year":"2024","unstructured":"Vermeiren MR, Calandri IL, van der Flier WM, van de Giessen E, Ossenkoppele R. Survey among experts on the future role of tau-PET in clinical practice and trials. Alzheimers Dement (Amst). 2024;16(4):e70033.","journal-title":"Alzheimers Dement (Amst)"},{"key":"7886_CR38","first-page":"271","volume":"141","author":"VJ Lowe","year":"2018","unstructured":"Lowe VJ, Wiste HJ, Senjem ML, et al. Widespread brain tau and its association with ageing. Braak Stage and Alzheimer\u2019s dementia Brain. 2018;141:271\u201387.","journal-title":"Braak Stage and Alzheimer\u2019s dementia Brain"},{"issue":"8","key":"7886_CR39","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214111","volume":"105","author":"L Trudel","year":"2025","unstructured":"Trudel L, Therriault J, Macedo AC, et al. Implication for clinical trials from longitudinal tau-PET accumulation across biological Alzheimer disease stages. Neurology. 2025;105(8):e214111.","journal-title":"Neurology"},{"issue":"6","key":"7886_CR40","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, et al. Donanemab in early symptomatic Alzheimer disease: The TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330(6):512\u201327.","journal-title":"JAMA"},{"issue":"5","key":"7886_CR41","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208061","volume":"102","author":"AS Fleisher","year":"2024","unstructured":"Fleisher AS, Munsie LM, Perahia DGS, et al. Assessment of efficacy and safety of zagotenemab: results from PERISCOPE-ALZ, a phase 2 study in early symptomatic Alzheimer disease. Neurology. 2024;102(5):e208061.","journal-title":"Neurology"},{"issue":"4","key":"7886_CR42","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.3233\/JAD-215558","volume":"88","author":"N Krishnadas","year":"2022","unstructured":"Krishnadas N, Huang K, Schultz SA, et al. Visually identified tau 18F-MK6240 PET patterns in symptomatic Alzheimer\u2019s disease. J Alzheimers Dis. 2022;88(4):1627\u201337.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"7886_CR43","doi-asserted-by":"publisher","first-page":"612","DOI":"10.2967\/jnumed.124.268700","volume":"66","author":"I Tunali","year":"2025","unstructured":"Tunali I, Wang J, Arora AK, et al. Development and validation of a 18F-flortaucipir PET visual stratification method. J Nucl Med. 2025;66(4):612\u20139.","journal-title":"J Nucl Med"},{"issue":"6","key":"7886_CR44","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00259-023-06583-9","volume":"51","author":"G Mathoux","year":"2024","unstructured":"Mathoux G, Boccalini C, Peretti DE, et al. A comparison of visual assessment and semi-quantification for the diagnostic and prognostic use of [18F]flortaucipir PET in a memory clinic cohort. Eur J Nucl Med Mol Imaging. 2024;51(6):1639\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"7886_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12372","volume":"9","author":"JL Shuping","year":"2023","unstructured":"Shuping JL, Matthews DC, Adamczuk K, et al. Development, initial validation, and application of a visual read method for [18F]MK-6240 tau PET. Alzheimers Dement (N Y). 2023;9(1):e12372.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"3","key":"7886_CR46","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000017038","volume":"9","author":"Z Nagy","year":"1998","unstructured":"Nagy Z, Yilmazer-Hanke DM, Braak H, Braak E, Schultz C, Hanke J. Assessment of the pathological stages of Alzheimer\u2019s disease in thin paraffin sections: a comparative study. Dement Geriatr Cogn Disord. 1998;9(3):140\u20134.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"7886_CR47","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s40478-023-01691-x","volume":"11","author":"JC Vizcarra","year":"2023","unstructured":"Vizcarra JC, Pearce TM, Dugger BN, et al. Toward a generalizable machine learning workflow for neurodegenerative disease staging with focus on neurofibrillary tangles. Acta Neuropathol Commun. 2023;11(1):202.","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"7886_CR48","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1002\/alz.13769","volume":"20","author":"T Earnest","year":"2024","unstructured":"Earnest T, Bani A, Ha SM, et al. Data-driven decomposition and staging of flortaucipir uptake in Alzheimer\u2019s disease. Alzheimers Dement. 2024;20(6):4002\u201319.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"7886_CR49","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1007\/s00259-025-07257-4","volume":"52","author":"G Bezgin","year":"2025","unstructured":"Bezgin G, Pascoal TA, Therriault J, et al. Tau profiling across Alzheimer\u2019s disease staging reveals vulnerability to disease pathophysiology. Eur J Nucl Med Mol Imaging. 2025;52(11):4281\u201391.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7886_CR50","doi-asserted-by":"publisher","first-page":"8232","DOI":"10.1038\/s41467-025-63564-2","volume":"16","author":"TE Anij\u00e4rv","year":"2025","unstructured":"Anij\u00e4rv TE, Ossenkoppele R, Smith R, et al. Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer\u2019s disease. Nat Commun. 2025;16:8232.","journal-title":"Nat Commun"},{"issue":"6","key":"7886_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70352","volume":"21","author":"Y Gu","year":"2025","unstructured":"Gu Y, Yun J, Moscoso A, et al. Integrating visual assessments and quantification methods for tau PET staging. Alzheimers Dement. 2025;21(6):e70352.","journal-title":"Alzheimers Dement"},{"issue":"13","key":"7886_CR52","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.1007\/s00259-025-07384-y","volume":"52","author":"EM Coomans","year":"2025","unstructured":"Coomans EM, van Tol B, Groot C, et al. Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [18F]flortaucipir imaging: TAU-SPEX. Eur J Nucl Med Mol Imaging. 2025;52(13):5135\u201349.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7886_CR53","doi-asserted-by":"crossref","unstructured":"Trudel L, Therriault J, Macedo AC, et al. Clinical-biological Alzheimer\u2019s disease stage concordance: Insights from cohorts and autopsy data. Brain. 2026;awag018.","DOI":"10.1093\/brain\/awag018"},{"issue":"7","key":"7886_CR54","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jamaneurol.2025.1100","volume":"82","author":"A Pichet-Binette","year":"2025","unstructured":"Pichet-Binette A, Smith R, Salvad\u00f3 G, et al. Evaluation of the revised criteria for biological and clinical staging of Alzheimer disease. JAMA Neurol. 2025;82(7):666\u201375.","journal-title":"JAMA Neurol"},{"issue":"1","key":"7886_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14338","volume":"21","author":"GD Rabinovici","year":"2025","unstructured":"Rabinovici GD, Knopman DS, Arbizu J, et al. Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer\u2019s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup. Alzheimers Dement. 2025;21(1):e14338.","journal-title":"Alzheimers Dement"},{"key":"7886_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2025.11.002","volume":"158","author":"E Aumont","year":"2026","unstructured":"Aumont E, Hall BJ, Chan T, et al. Optimized atlas for early tau-PET staging via native space segmentations. Neurobiol Aging. 2026;158:1\u201310.","journal-title":"Neurobiol Aging"},{"key":"7886_CR57","doi-asserted-by":"publisher","DOI":"10.1162\/imag_a_00402","volume":"2","author":"C Lois","year":"2024","unstructured":"Lois C, Fu JF, Salvatore AN, et al. Test-retest performance of [ 18 F]MK-6240 tau burden and relative delivery indices in cognitively normal older subjects using PET\/MRI. Imaging Neurosci. 2024;2:imag-2-00402.","journal-title":"Imaging Neurosci"},{"issue":"1","key":"7886_CR58","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13550-021-00790-x","volume":"11","author":"GD Kolinger","year":"2021","unstructured":"Kolinger GD, V\u00e1llez Garc\u00eda D, Lohith TG, et al. A dual-time-window protocol to reduce acquisition time of dynamic tau PET imaging using [18F]MK-6240. EJNMMI Res. 2021;11(1):49.","journal-title":"EJNMMI Res"},{"key":"7886_CR59","doi-asserted-by":"publisher","first-page":"102708","DOI":"10.1016\/j.nicl.2021.102708","volume":"31","author":"R Smith","year":"2021","unstructured":"Smith R, Strandberg O, Leuzy A, et al. Sex differences in off-target binding using tau positron emission tomography. Neuroimage Clin. 2021;31:102708.","journal-title":"Neuroimage Clin"},{"issue":"1","key":"7886_CR60","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2967\/jnumed.124.267539","volume":"66","author":"A Aliaga","year":"2025","unstructured":"Aliaga A, Therriault J, Quispialaya KM, et al. Comparison between brain and cerebellar autoradiography using [18F]flortaucipir, [18F]MK6240, and [18F]PI2620 in postmortem human brain tissue. J Nucl Med. 2025;66(1):123\u20139.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07886-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07886-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07886-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:16:30Z","timestamp":1785521790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07886-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["7886"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07886-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study received approval from the Montreal Neurological Institute (MNI) PET working committee and the Douglas Mental Health University Institute Research Ethics Board (IUSMD 16\u201360). All participants signed informed consent forms. This study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KP has served as a consultant for Eli Lilly, Biospective, and Optina Diagnostics. Dr GTB reported being an employee of Janssen R&D during the conduct of the study and having a patent for Plasma p217\u2009+\u2009tau assay pending. HK reported being an employee of Janssen R&D during the conduct of the study and having a patent for p217Tau plasma assay pending. Outside the work presented in this paper, PRN provides consultancy services for Roche, Cerveau Radiopharmaceuticals, Lilly, Eisai, Pfizer, and Novo Nordisk. PRN also serves as a clinical trials investigator for Biogen, Novo Nordisk, and Biogen. The other authors report no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}